Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.27 USD | -0.47% | -2.88% | -11.34% |
01:59pm | Stephens Initiates Exelixis With Equalweight Rating, $23 Price Target | MT |
05-10 | Exelixis Files Patent Complaint Against Cipla's Cancer Treatment | DJ |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
EXELIXIS, INC. | Bio Therapeutic Drugs | -0.47% | -2.88% | -11.34% | +10.90% | +12.36% | 6.2B |
- Stock Market
- Equities
- EXEL Stock
- Charts Exelixis, Inc.
- Relative Strength Chart